← Leaderboards
Xuesi Max Shao
Afasci, Inc.
$2,257,934
Attributed
$4,515,867
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $900.6K · FY2011–21$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,515,867 · 5
By mechanism
R01$2,251,276 · 1
R44$990,659 · 1
R42$883,548 · 1
R43$240,384 · 1
R41$150,000 · 1
Top collaborators
- Daliao Xiao5 shared
- Josef Kewekordes3 shared
- Xinmin Simon Xie3 shared
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsRattusRodentDrug KineticsCigarette SmokingResponseTechnologyGenerationsNicotineBloodChronicAnimal ModelAerosolsDoseLegal PatentExposure ToAlveolarLungPregnancyCardiovascular SystemBlood CirculationCigaretteBlood PressureElectronic Cigarette
Grant awards (11)
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$430,503
R01 · FY2021 · HL
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$440,741
R01 · FY2020 · HL
Developing an efficient E-cigarette aerosol generation and exposure system for rodent models with aerosol characteristics equivalent to those inhaled by E-cigarette users$430,053
R42 · FY2020 · DA
Developing an efficient E-cigarette aerosol generation and exposure system for rodent models with aerosol characteristics equivalent to those inhaled by E-cigarette users$453,495
R42 · FY2019 · DA
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$447,061
R01 · FY2019 · HL
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$456,811
R01 · FY2018 · HL
Developing an efficient E-cigarette aerosol generation and exposure system for rodent models with aerosol characteristics equivalent to those inhaled by E-cigarette users$150,000
R41 · FY2018 · DA
Maternal inhaled nicotine leads to aberrant development of hypertensive phenotype$476,160
R01 · FY2017 · HL
Nicotine delivery to rodent with lung alveolar region-targeted aerosol technology$484,537
R44 · FY2014 · DA
Nicotine delivery to rodent with lung alveolar region-targeted aerosol technology$506,122
R44 · FY2013 · DA
Nicotine delivery to rodents with lung alveolar region-targeted aerosol tech$240,384
R43 · FY2011 · DA